Torrent Pharma Financial Statements

Torrent Pharma (TORNTPHARM) reported revenue of ₹138.86B in FY2026 with net income of ₹21.38B. Total assets stood at ₹443.13B and free cash flow was ₹23.45B.

Torrent Pharma Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		115.39B	138.86B
Cost of Rev. Cost of Revenue		-33.26B	-33.88B
Gross Profit		82.13B	104.98B
SGA Sales, General & Admin		-50.19B	-60.33B
Op. Income Operating Income		23.99B	33.46B
PBT Profit Before Tax		26.73B	28.72B
Net Income		19.11B	21.38B
Dil. Shares Diluted Shares		338.41M	338.39M
Diluted EPS		56.47	63.92

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Torrent Pharma's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Torrent Pharma Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		56.23B	93.92B
Non-curr. assets Total non-current assets		93.67B	349.21B
Total assets		149.90B	443.13B
Curr. liabilities Total current liabilities		47.17B	83.43B
Non-curr. liab. Total non-current liabilities		26.82B	183.84B
Total liabilities		73.99B	267.27B
Total equity		75.91B	175.85B
Total liab. & eq. Total liabilities & equity		149.90B	443.12B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Torrent Pharma's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Torrent Pharma Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		26.73B	28.72B
Operating CF Cash flow Operating Activities		25.85B	30.23B
Capex Investments in PPE		-6.12B	-6.77B
Investing CF Cash flow Investing Activities		-5.40B	-127.12B
Dividend Paid		-10.83B	-12.89B
Financing CF Cash flow Financing Activities		-22.98B	101.51B
Cash (start) Cash at beginning of period		8.35B	5.73B
Cash (end) Cash at end of period		5.73B	11.17B
FCF Free Cash Flow		19.73B	23.45B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Torrent Pharma's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026